{"id":"https://openalex.org/W4387312340","doi":"https://doi.org/10.1158/1535-7163.mct-23-0353","title":"Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody\u2013Drug Conjugate for Treatment of CLDN18.2-Positive Cancers","display_name":"Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody\u2013Drug Conjugate for Treatment of CLDN18.2-Positive Cancers","publication_year":2023,"publication_date":"2023-10-03","ids":{"openalex":"https://openalex.org/W4387312340","doi":"https://doi.org/10.1158/1535-7163.mct-23-0353","pmid":"https://pubmed.ncbi.nlm.nih.gov/37788341"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-23-0353","doi":"https://doi.org/10.1158/1535-7163.mct-23-0353","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-23-0353","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028010756","display_name":"Neil A. O\u2019Brien","orcid":"https://orcid.org/0000-0001-7408-1091","observed_orcids":["https://orcid.org/0000-0001-7408-1091"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil A. O'Brien","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0001-7408-1091","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000509598","display_name":"Martina S.J. McDermott","orcid":"https://orcid.org/0000-0001-5737-7202","observed_orcids":["https://orcid.org/0000-0001-5737-7202"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martina S.J. McDermott","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0001-5737-7202","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062082536","display_name":"Jun Zhang","orcid":"https://orcid.org/0000-0001-6049-0572","observed_orcids":["https://orcid.org/0000-0001-6049-0572"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jun Zhang","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0001-6049-0572","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002335972","display_name":"KeWei Gong","orcid":"https://orcid.org/0000-0002-3890-3761","observed_orcids":["https://orcid.org/0000-0002-3890-3761"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ke Wei Gong","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0002-3890-3761","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019314293","display_name":"Ming Lu","orcid":"https://orcid.org/0000-0003-1574-9850","observed_orcids":["https://orcid.org/0000-0003-1574-9850"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ming Lu","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0003-1574-9850","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070780127","display_name":"Benjamin Hoffstrom","orcid":"https://orcid.org/0000-0002-7469-3028","observed_orcids":["https://orcid.org/0000-0002-7469-3028"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Hoffstrom","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0002-7469-3028","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013404372","display_name":"Tong Luo","orcid":"https://orcid.org/0000-0001-5382-7448","observed_orcids":["https://orcid.org/0000-0001-5382-7448"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tong Luo","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0001-5382-7448","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039664664","display_name":"Raul Ayala","orcid":"https://orcid.org/0009-0006-1044-2031","observed_orcids":["https://orcid.org/0009-0006-1044-2031"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raul Ayala","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0009-0006-1044-2031","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063951168","display_name":"Kevin Chau","orcid":"https://orcid.org/0000-0001-9945-9169","observed_orcids":["https://orcid.org/0000-0001-9945-9169"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Chau","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0001-9945-9169","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044485794","display_name":"Min Liang","orcid":"https://orcid.org/0000-0002-9740-7688","observed_orcids":["https://orcid.org/0000-0002-9740-7688"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Min Liang","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0002-9740-7688","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064775999","display_name":"Athena M. Madrid","orcid":"https://orcid.org/0009-0000-8115-1393","observed_orcids":["https://orcid.org/0009-0000-8115-1393"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Athena M. Madrid","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0009-0000-8115-1393","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058851560","display_name":"Timothy R. Donahue","orcid":"https://orcid.org/0000-0002-1175-2545","observed_orcids":["https://orcid.org/0000-0002-1175-2545"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4390039293","display_name":"UCLA Jonsson Comprehensive Cancer Center","ror":"https://ror.org/0599cs764","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I4390039293"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy R. Donahue","raw_affiliation_strings":["2Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0002-1175-2545","affiliations":[{"raw_affiliation_string":"2Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4390039293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A. Glaspy","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0002-1800-9076","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010670943","display_name":"Leonard Presta","orcid":"https://orcid.org/0000-0002-7871-1991","observed_orcids":["https://orcid.org/0000-0002-7871-1991"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leonard Presta","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0002-7871-1991","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":["1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California"],"raw_orcid":"https://orcid.org/0000-0002-6330-498X","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.005,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.92089571,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"22","issue":"12","first_page":"1365","last_page":"1375"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cldn18-2","display_name":"CLDN18.2","score":0.996999979019165},{"id":"https://openalex.org/keywords/claudin-18-2","display_name":"claudin 18.2","score":0.8259999752044678},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9440000057220459},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":1.0},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.6259999871253967},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.8999999761581421},{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.6830000281333923},{"id":"https://openalex.org/keywords/monomethyl-auristatin-e","display_name":"monomethyl auristatin E","score":0.8360000252723694},{"id":"https://openalex.org/keywords/cleavable-linkers","display_name":"cleavable linkers","score":0.8889999985694885},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9559999704360962},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7509999871253967},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8939999938011169},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C51872919","wikidata":"https://www.wikidata.org/wiki/Q420863","display_name":"Claudin","level":3,"score":0.5821261405944824},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5416186451911926},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5162229537963867},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.4857914447784424},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4690912961959839},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.46907681226730347},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43751391768455505},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.43723347783088684},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39445924758911133},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3114008903503418},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29624253511428833},{"id":"https://openalex.org/C177779419","wikidata":"https://www.wikidata.org/wiki/Q1053832","display_name":"Tight junction","level":2,"score":0.1541908085346222},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13456299901008606},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09715265035629272}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057167","descriptor_name":"Claudins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-23-0353","doi":"https://doi.org/10.1158/1535-7163.mct-23-0353","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-23-0353","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:37788341","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37788341","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1508010721","https://openalex.org/W1554042779","https://openalex.org/W2007895431","https://openalex.org/W2047419828","https://openalex.org/W2079482620","https://openalex.org/W2108902851","https://openalex.org/W2125372085","https://openalex.org/W2157473448","https://openalex.org/W2792066790","https://openalex.org/W2809428231","https://openalex.org/W2891199715","https://openalex.org/W2948140451","https://openalex.org/W2955746156","https://openalex.org/W2966500633","https://openalex.org/W3119672772","https://openalex.org/W3132443161","https://openalex.org/W3147820834","https://openalex.org/W3180471575","https://openalex.org/W3197559541","https://openalex.org/W4210990885","https://openalex.org/W4220847494","https://openalex.org/W4229445969","https://openalex.org/W4252968802","https://openalex.org/W4298148770","https://openalex.org/W4307909027","https://openalex.org/W4318904009","https://openalex.org/W4365813058","https://openalex.org/W4379282704","https://openalex.org/W4379282721"],"related_works":["https://openalex.org/W4282978458","https://openalex.org/W2948140451","https://openalex.org/W4388042394","https://openalex.org/W3181651719","https://openalex.org/W7166134113","https://openalex.org/W3110482033","https://openalex.org/W7148771602","https://openalex.org/W4282979504","https://openalex.org/W4380029577","https://openalex.org/W4393095078"],"abstract_inverted_index":{"Gastric":[0],"and":[1,37,44,124,140,162,171,178,200,221],"pancreatic":[2,180,203],"cancers":[3],"are":[4,229],"malignancies":[5],"of":[6,12,39,66,104,137,154,186,194,197,202,211,218,225],"high":[7,118],"unmet":[8],"clinical":[9,216,236],"need.":[10],"Expression":[11],"CLDN18.2":[13,52,96,105],"in":[14,60,175,233],"these":[15],"cancers,":[16],"coupled":[17],"with":[18,117,131],"it's":[19],"absence":[20],"from":[21],"most":[22],"normal":[23],"tissues,":[24,189],"provides":[25],"a":[26,40,99,112],"potential":[27],"therapeutic":[28,42],"window":[29],"against":[30],"this":[31,132,155],"target.":[32],"We":[33],"present":[34],"preclinical":[35],"development":[36,217],"characterization":[38],"novel":[41],"mAb":[43,69,97],"antibody-drug":[45],"conjugate":[46],"(ADC)":[47],"targeting":[48],"CLDN18.2.":[49,84,212],"A":[50,85,184],"humanized":[51],"specific":[53],"mAb,":[54],"CLDN18.2-307-mAb,":[55],"was":[56,89,106,160],"generated":[57,91],"through":[58],"immunization":[59],"mice":[61],"followed":[62],"by":[63,75,92,108,190],"full":[64],"humanization":[65],"the":[67,135,151,157,166,219],"mouse":[68],"sequences.":[70],"Antibody":[71],"clones":[72],"were":[73],"screened":[74],"flow":[76],"cytometry":[77],"for":[78,208,223],"selective":[79],"binding":[80,149],"to":[81,95,120,150,165,205],"membrane":[82,209],"bound":[83],"CLDN18.2-directed":[86],"ADC":[87],"(CLDN18.2-307-ADC)":[88],"also":[90],"conjugating":[93],"MMAE":[94],"using":[98,111],"cleavable":[100],"linker.":[101],"Tissue":[102],"expression":[103,210],"determined":[107],"IHC":[109],"assay":[110],"CLDN18.2-specific":[113],"mAb.":[114],"CLDN18.2-307-mAb":[115,220],"binds":[116],"affinity":[119],"CLDN18.2-positive":[121],"(CLDN18.2+)":[122],"cells":[123],"induces":[125],"antibody-dependent":[126],"cell-mediated":[127],"cytotoxicity":[128],"(ADCC).":[129],"Treatment":[130],"CLDN18.2-mAb":[133],"blocked":[134],"growth":[136],"CLDN18.2+":[138,176,226],"gastric":[139],"pancreas":[141],"cancer":[142,181,188],"cell":[143],"line":[144],"xenograft":[145],"(CDX)":[146],"models.":[147],"Upon":[148],"extracellular":[152],"domain":[153],"target,":[156],"CLDN18.2-ADC/CLDN18.2":[158],"protein":[159],"internalized":[161],"subsequently":[163],"localized":[164],"lysosomal":[167],"compartment":[168],"inducing":[169],"complete":[170],"sustained":[172],"tumor":[173],"regressions":[174],"CDXs":[177],"patient-derived":[179],"xenografts":[182],"(PDX).":[183],"screen":[185],"human":[187],"IHC,":[191],"found":[192],"58%":[193],"gastric,":[195],"60%":[196],"gastroesophageal":[198],"junction,":[199],"20%":[201],"adenocarcinomas":[204],"be":[206],"positive":[207],"These":[213],"data":[214],"support":[215],"CLDN18.2-307-ADC":[222],"treatment":[224],"cancers.":[227],"Both":[228],"now":[230],"being":[231],"investigated":[232],"phase":[234],"I":[235],"studies.":[237]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-10-04T00:00:00"}